Neuroscience

A prescription for exercise

Richard Carpenter, 75, was going through the mail one day last year when he saw a postcard from UCI seeking participants for a study on whether exercise can help with age-related memory loss.

Neuroscience

A prescription for exercise

Richard Carpenter, 75, was going through the mail one day last year when he saw a postcard from UCI seeking participants for a study on whether exercise can help with age-related memory loss.

Oncology & Cancer

Benlysta approved for children with lupus

(HealthDay)—The intravenous drug Benlysta (belimumab) has been approved by the U.S. Food and Drug Administration to treat children with lupus, a chronic disease that triggers inflammation and damages tissues and organs ...

Neuroscience

FDA OKs new drug for multiple sclerosis

(HealthDay)—A new pill for relapsing forms of multiple sclerosis (MS) has won approval from the U.S. Food and Drug Administration.

Medications

FDA approves first drug for rare form of rickets

(HealthDay)—Ultragenyx Pharmaceutical Inc.'s Crysvita (burosumab-twza) has been approved by the U.S. Food and Drug Administration to treat adults and children ages 1 year and older with x-linked hypophosphatemia (XLH).

Medical research

Kalydeco approval widened for more types of cystic fibrosis

(HealthDay)—The U.S. Food and Drug Administration says it has expanded approval for the cystic fibrosis drug Kalydeco (ivacaftor) to include 33 mutations of the disease, up from the previous 10 mutations.

Medications

FDA approves ocaliva for primary biliary cholangitis

(HealthDay)—Ocaliva (obeticholic acid) has been approved by the U.S. Food and Drug Administration to treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with inadequate response ...

page 1 from 5